| Literature DB >> 26167484 |
Haitao Lan1, Charat Thongprayoon2, Adil Ahmed3, Vitaly Herasevich4, Priya Sampathkumar5, Ognjen Gajic2, John C O'Horo6.
Abstract
Ventilator-associated events (VAEs) are associated with increased risk of poor outcomes, including death. Bundle practices including thromboembolism prophylaxis, stress ulcer prophylaxis, oral care, and daily sedation breaks and spontaneous breathing trials aim to reduce rates of VAEs and are endorsed as quality metrics in the intensive care units. We sought to create electronic search algorithms (digital signatures) to evaluate compliance with ventilator bundle components as the first step in a larger project evaluating the ventilator bundle effect on VAE. We developed digital signatures of bundle compliance using a retrospective cohort of 542 ICU patients from 2010 for derivation and validation and testing of signature accuracy from a cohort of random 100 patients from 2012. Accuracy was evaluated against manual chart review. Overall, digital signatures performed well, with median sensitivity of 100% (range, 94.4%-100%) and median specificity of 100% (range, 100%-99.8%). Automated ascertainment from electronic medical records accurately assesses ventilator bundle compliance and can be used for quality reporting and research in VAE.Entities:
Mesh:
Year: 2015 PMID: 26167484 PMCID: PMC4475726 DOI: 10.1155/2015/396508
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Figure 1Flow chart for digital signature derivation and validation. This model was applied to all signatures developed in the present study.
Bundle components and definitions. The “medical definition” refers to the objective of the bundle element. The “EMR definition” is how we operationalized this for our digital signature. The EMR section used refers to portions of the patient chart searched with the digital signature for the bundle element.
| Ventilator compliance bundle element | Medical definition | EMR definition | EMR section used |
|---|---|---|---|
| DVT prophylaxis | The presence of an appropriate anticoagulant within 24-hour period | The systemic administration of one of the following medications within 24 hours regardless of dosage use: | Medication administration record, fluid data |
|
| |||
| Peptic ulcer prophylaxis | The presence of an appropriate acid-inhibitory drug or sucralfate within 24-hour period | The systemic administration of one of the following medications within 24 hours regardless of dosage use: | Medication administration record, fluid data |
|
| |||
| Oral care | The presence of chlorhexidine oral care within 24-hour period | The use of chlorhexidine oral rinse within 24 hours | Medication administration record |
|
| |||
| Head of bed elevation | ≥30 degree consistently documented within 24-hour period | The patient position was one of the following: | Nursing flow sheet |
|
| |||
| Sedation break | If continuous IV sedation is present, any continuous intravenous sedatives or opioids break for ≥ 15 minutes was performed within 24 hour period | (1) Identify the continuous IV administration of one of the following medications within 24 hours regardless of duration and dosage use: | Fluid data |
Excepting heparin locks and line flushes.
Clinical characteristics of derivation and validation cohort.
| Variable | Derivation cohort | Validation cohort |
|
|---|---|---|---|
|
| 542 | 100 | |
| Age (year) | 63 ± 17 | 62 ± 17 | 0.59 |
| Male sex | 311 (57) | 61 (61) | 0.51 |
| White | 477 (88) | 90 (90) | 0.73 |
| Medical ICU | 207 (38) | 51 (51) | <0.01 |
| Admission SOFA score | 8 ± 3 | 8 ± 4 | 0.99 |
| Admission APACHE score | 76 ± 25 | 85 ± 27 | <0.01 |
| MV use on reviewed day# | 352 (65) | 100 (100) | <0.01 |
| ICU length of stay (day) | 2.4 (1.5–5.3) | 5.8 (2.8–10.7) | <0.01 |
| ICU mortality | 34 (6) | 7 (7) | 0.82 |
| Hospital mortality | 54 (10) | 14 (14) | 0.22 |
Continuous data are presented as mean ± SD if normally distributed, median (25th percentile–75th percentile) for nonnormal data; categorical variables are reported as count (%).
#ICU day 2 for derivation cohort and mechanical ventilator day 2 for validation cohort.
P value calculated by Fisher Chi-Square for categorical variables, Student's t-test for normally distributed continuous variables, and Wilcoxon rank-sum for nonparametric analysis.
Sensitivity, specificity, and the concordance and discordance between electronic data extraction result and reference standard in derivation and validation cohort.
| Item | Cohort | Number of patients | Sensitivity | Specificity | TP | TN | FP | FN |
|---|---|---|---|---|---|---|---|---|
| DVT prophylaxis | DC | 542 | 91.7 (87.7–94.7) | 93.5 (89.9–96.1) | 243 | 259 | 18 | 22 |
| VC | 100 | 100 (92.8, 100) | 100 (92.8, 100) | 50 | 50 | 0 | 0 | |
|
| ||||||||
| Peptic ulcer prophylaxis | DC | 542 | 94.1 (91.0–96.3) | 96.6 (93.1–98.6) | 317 | 198 | 7 | 20 |
| VC | 100 | 100 (95.9, 100) | 100 (95.9, 100) | 89 | 11 | 0 | 0 | |
|
| ||||||||
| Oral care | DC | 542 | 100 (96.7–100) | 99.8 (98.7–100) | 111 | 430 | 1 | 0 |
| VC | 100 | 100 (95, 100) | 100 (87, 100) | 73 | 27 | 0 | 0 | |
|
| ||||||||
| Head of bed elevation | DC | 542 | 96.5 (95.5–97.9) | 50 (32.4–67.6) | 490 | 17 | 17 | 18 |
| VC | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
|
| ||||||||
| Sedation break | DC | 254 | 100 (98.3–100) | 87.9 (71.8–96.5) | 221 | 29 | 4 | 0 |
| VC | 73 | 94.4 (84.6, 98.8) | 100 (83, 100) | 51 | 20 | 0 | 3 | |
CI: confidence interval; DC: derivation cohort; VC: validation cohort; DVT: deep vein thrombosis; TP: true positive; FP: false positive; TN: true negative; FN: false negative.
Because we could never achieve high specificity with the head of bed elevation in the derivation cohort, we did not attempt validation.
Only patients on sedation at any point during the test day were assessed for “sedation break.”